Apoptosis of mature B cells

International Reviews of Immunology

Volumn 18, Issue 4, 1999, Pages 347-365

  Tsubata, Takeshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; B cell; BCR; CD40; CD95

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; APOPTOSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HUMANS; RECEPTORS, ANTIGEN, B-CELL;

EID: 0032585779     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189909088488     Document Type: Article

References (96)

1. K. Rajewsky, Clonal selection and learning in the antibody system. Nature 381, 751-8, 1996.
2. K.P. Lam, R, Kuhn and K. Rajewsky. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-83, 1997.
3. J. Wienands, O. Larbolette and M. Reth. Evidence for a preformed transducer complex organized by the B cell antigen receptor, Proc. Natl. Acad. Sci. USA 93, 7865-70, 1996.
4. K. Nakayama, K. Nakayama, I. Negishi, K. Kuida, H. Sawa and D.Y. Loh. Targeted disruption of Bcl-2 alpha beta in mice, occurrence of gray hair, polycystic kidney disease, and lymphocytopema. Proc. Natl. Acad. Sci USA 91, 3700-4, 1994.
5. K. Nakayama, K. Nakayama, I. Negishi, K. Kuida, Y. Shinkai, M.C. Louie, L.E. Fields, P.J, Lucas, V. Stewart, F W. Alt et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261, 1584-8, 1993.
6. D.J. Veis, C.M. Sorenson, J. R. Shutter and S.J. Korsmeyer. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair, Cell 75, 229-40, 1993.
7. G. Nunez, R. Merino, D. Grillot and G-M. Gonzalez. Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol. Today 15, 582-8, 1994.
8. A B. Kantor and L.A. Herzenberg. Origin of murine B cell lineages. Annu Rev. Immunol, 11, 501-38, 1993.
9. M. Murakami, T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura and T. Honjo. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357, 77-80, 1992.
10. M. Okamoto, M. Murakami, A. Shimizu, S. Ozaki, T Tsubata, S. Kumagai and T. Honjo. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175, 71-9, 1992.
11. D. Nemazee and K. Bürki. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562-6, 1989.
12. S.B. Hartley, J. Crosbie, R. Brink, A.B. Kantor, A. Basten and C.C. Goodnow. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353, 765-9, 1991.
13. T. Tsubata, M. Murakami and T. Honjo. Antigen-receptor cross-linking induces peritoneal B-cell apoptosis in normal but not autoimmunity-prone mice. Curr. Biol. 4, 8-17, 1994.
14. J. Lang, B. Arnold, G. Hammerling, A.W. Harris, S. Korsmeyer, D. Rusell, A. Strasser and D. Nemazee. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive immature B cells. J. Exp. Med. 186, 1513-22, 1997.
15. S.L. Parry, J. Hasbold, M. Holman and G.G. Klaus. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 152, 2821-9, 1994.
16. S.L. Parry, M.J. Holman, J. Hasbold and G.G. Klaus. Plastic-immobilized antimu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 24, 974-9, 1994.
17. N. Chaouchi, A. Vazquez, P. Galanaud and C. Leprince. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J. Immunol. 154, 3096-104, 1995.
18. D.A. Fulcher, A.B. Lyons, S.L. Korn, M.C. Cook, C. Koleda, C. Parish, D.S. Fazekas, B. Groth and A. Basten. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183, 2313-28, 1996.
19. M. Brunswick, F.D. Finkelman. P.F. Highet, J.K. Inman and H.M. Dintzis. Picogram quantities of anti-Ig antibodies coupled to. J. Immunol. 140, 3364-72, 1988.
20. C.M. Snapper, T.M. McIntyre, R. Mandler, L.M. Pecanha, F.D. Finkelman and A. Lees. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent type 2 antigens. J. Exp. Med. 175, 1367-71, 1992.
21. E. Pure and E. Vitetta. Induction of murine B cell proliferation by insolubilized anti-immunoglobulins. J. Immunol. 125, 1240-2, 1980.
22. D.C. Parker. Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin. Nature 258, 361-3, 1975.
23. F.D. Finkelman, J.M. Holmes, O.I Dukhanina and S.C. Morris. Cross-linking of membrane immunoglobulin D. in the absence of T cell help, kills mature B cells in vivo. J. Exp. Med. 181, 515-25, 1995.
24. D.A. Fulcher and A. Basten. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 179, 125-34, 1994.
25. H. Tighe, K. Warnatz, D. Brinson, M. Corr, W.O. Weigle, S.M. Baird and D.A. Carson. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc. Natl. Acad. Sci. USA 94, 646-51, 1997.
26. Y. Kozono, B.L. Kotzin and V.M. Holers. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J Immunol. 156, 4498-503. 1996.
27. D.C. Parker Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti-IgD on murine B cells, Immunol. Rev. 52, 115-39, 1980.
28. V. Udhayakumar, L. Kumar and B. Subbarao. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. J. Immunol. 146, 4120-9, 1991.
29. J.S. Andersen, M. Teutsch, Z. Dong and H.H. Wortis. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci USA 93, 10966-71, 1996.
30. M.S. Choi, M. Holman, C.J. Atkins and G.G. Klaus. Expression of blc-x during mouse B cell differentiation and following activation by various stimuli. Eur. J. Immunol. 26, 676-82, 1996.
31. D.L. Morris and T.L. Rothstein. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-I lymphocytes. J. Exp. Med. 177, 857-61, 1993.
32. G. Bikah, J. Carey, J. R. Ciallella, A. Tarakhovsky and S. Bondada. CDS-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274, 1906-9, 1996.
33. G. Pani, K.D. Fischer, R.I. Mlinaric and K.A. Siminovitch. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184, 839-52, 1996.
34. J.G. Cyster and C.C. Goodnow. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 6, 509-17, 1997.
35. C.C. Goodnow, J.G. Cyster, S.B. Hartley, S.E. Bell, M.P. Cooke, J.I. Healy, S Akkaraju, J.C. Rathmell, S.L. Pogue and K.P. Shokat. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59, 279-368, 1995.
36. R. Carsetti, G Kohler and M.C. Lamers. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181, 2129-40, 1995.
37. D.M. Russell, Z. Dembic, G. Morahan, J.F. Miller, K. Burki and D. Nemazee. Peripheral deletion of self-reactive B cells. Nature 354, 308-11, 1991.
38. B. Diamond and M.D. Scharff. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity, Proc. Natl. Acad. Sci. USA 81, 5841-4, 1984.
39. A.M. Giusti, N.C. Chien, D.J. Zack, S.U. Shin and M.D. Scharff. Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region. Proc. Natl. Acad. Sci. USA 84, 2926-30, 1987.
40. G. Kelsoe. In situ studies of the germinal center reaction Adv. Immunol. 60, 267-88, 1995.
41. I. MacLennan, P.M. Casamayor, K.M. Toellner, J.A. Gulbranson and J. Gordon. Memory B-cell clones and the diversity of their members. Sem. Immunol. 9, 229-34, 1997.
42. B. Pulendran, G. Kannourakis, S. Nouri, K.G. Smith and G.J. Nossal. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375, 331-4, 1995.
43. K.M. Shokat and C.C. Goodnow. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375, 334-8, 1995
44. T. Nomura, H. Han, M.C. Howard, H. Yagita, H. Yakura, T. Honjo and T. Tsubata. Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice. Int. Immunol. 8, 867-75, 1996.
45. M.A. Valentine and K.A. Licciardi. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD4O. Eur. J. Immunol. 22, 3141-8, 1992.
46. A.L Santos, J. Gordon, A.W. Heath and M. Howard. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest. Cell. Immunol. 156, 272-85, 1994.
47. A.W Heath, W.W. Wu and M.C. Howard Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur, J. Immunol. 24, 828-34, 1994.
48. S. Lederman, M.J. Yellin, A.M. Cleary, A. Pernis, G. Inghirami, L.E. Cohn, L.R. Covey, J.J. Lee, P. Rothman and L. Chess. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 152, 2163-71, 1994.
49. A.W. Boyd and J.W Schrader. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. J. Immunol. 126, 2466-9, 1981.
50. J. Banchereau, F. Bazan, D. Blanchard, F Briere, J.P. Galizzi, K.C. van, Y.J. Rousset, F. Rousset and S, Saeland. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922, 1994.
51. L.C. Johnson, J. Hasbold, M. Holman and G.G. Klaus. The effects of IFN-gamma on CD40-mediated activation of B cells from X-Iinked immunodeficient or normal mice. J. Immunol. 159, 1150-9, 1997,
52. A.M. Genaro, J.A. Gonzalo, L. Bosca and C. Martinez. CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression. Eur. J. Immunol. 24, 2515-21, 1994.
53. M.S. Choi, L.H. Boise, A.R. Gottschalk, J. Quintans, C.B. Thompson and G.G. Klaus, The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 25, 1352-7, 1995.
54. T. Ishida, N. Kobayashi, T. Tojo, S. Ishida, T. Yamamoto and J. Inoue. CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J. Immunol. 155, 5527-35, 1995.
55. Z. Wang, J.G. Karras, R.G. Howard and T.L. Rothstein. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J. Immunol. 155, 3722-5, 1995.
56. S. Nisitam, T. Tsubata, M. Murakami, M. Okamoto and T. Honjo. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp. Med. 78, 1247-54, 1993.
57. R. Merino, D.A. Grillot, P.L. Simonian, S. Muthukkumar, W.C. Fanslow, S. Bondada and G. Nunez. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J. Immunol. 155, 3830-8, 1995.
58. W. Fang, J.J. Rivard, J.A. Ganser, T.W. LeBien, K.A. Nath, D.L. Mueller and T.W. Behrens. Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 155, 66-75, 1995.
59. G.E. Sonenshein. Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion J. Immunol. 158, 1994-7, 1997.
60. T.F. Tedder, M. Inaoki and S. Sato. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6, 107-18, 1997.
61. Y. Kozono, R.C. Duke, M.S. Schleicher and V.M. Holers. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur. J. Immunol. 25, 1013-7, 1995.
62. J.C. Unkeless and J. Jin. Inhibitory receptors, ITIM sequences and phosphatases. Curr. Opin. Immunol. 9, 338-43, 1997.
63. [62a] T. Adachi, H. Flaswinkel, H. Yakura, M. Reth and T. Tsubata. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-I upon tyrosine phosphorylation. J. Immunol. 160, 4662-5, 1998.
64. T.L. Rothstein, J.K. Wang, D.J- Panka, L.C. Foote, Z. Wang, B. Stanger, H. Ju, S.T. Ju and R. A. Marshak. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-5, 1995.
65. K. Nakanishi. K. Matsui, S, Kashiwamura, Y. Nishioka, J. Nomura, Y. Nishimura, N. Sakaguchi, S. Yonehara, K. Higashino and S. Shinka. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation. Int. Immunol. 8, 791-8, 1996.
66. P. Garrone, E.M. Neidhardt, E. Garcia, L, Galibert, K.C. van and J. Banchereau. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182, 1265-73, 1995.
67. E.J. Schattner, K.B. Elkon, D.H. Yoo, J. Tumang, P.H. Krammer, M.K. Crow and S.M. Friedman. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182, 1557-65, 1995.
68. J. Wang, I. Taniuchi, Y. Maekawa, M. Howard, M.D. Cooper and T. Watanabe. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 26, 92-6, 1996,
69. S. Nagata and P. Golstein. The Fas death factor. Science 267, 1449-56, 1995.
70. H. Yagita, S. Hanabuchi, Y. Asano, T. Tamura, H. Nariuchi and K. Okumura. Fas-mediated cytotoxicity - a new immunoregulatory and pathogenic function of Th1 CD4+ T cells. Immunol. Rev. 146, 223-39, 1995.
71. C. Lagresle, P. Mondiere, C. Bella, P.H. Krammer and T. Defrance. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J. Exp. Med. 183, 1377-88, 1996.
72. L.C. Foote, R.G. Howard, R.A. Marshak and T.L. Rothstein. IL-4 induces Fas resistance in B cells. J. Immunol. 157, 2749-53, 1996.
73. T. Takahashi, M. Tanaka, C.I- Brannan, N.A. Jenkins, N.G. Copeland, T. Suda and S. Nagata. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-76, 1994.
74. F.R, Watanabe, C.I. Brannan, N.G. Copeland, N.A. Jenkins and S. Nagata. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-7, 1992.
75. L.F. Rieux, D.F. Le, C. Hivroz, I.A. Roberts, K.M. Debatin, A. Fischer and V.J. de. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-9, 1995.
76. G.H. Fisher, FJ. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, M.J. Lenardo and J.M. Puck. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-46, 1995.
77. J.C. Rathmell and C.C. Goodnow. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 153, 2831-42, 1994.
78. J.C. Rathmell, M.P. Cooke. W.Y. Ho, J Grein, S.E. Townsend, M.M. Davis and C.C. Goodnow. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376, 181-4, 1995.
79. M.P. Cooke, A W. Heath, K.M. Shokat, Y. Zeng, F.D Finkelman, P.S. Linsley, M, Howard and C C. Goodnow. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp, Med. 179, 425-38, 1994
80. J.C. Rathmell, S E. Townsend, J.C. Xu, R.A. Flavell and C.C. Goodnow. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87, 319-29, 1996.
81. C.C. Goodnow, R. Brink and E. Adams. Breakdown of self-tolerance in anergic B lymphocytes. Nature 352, 532-6, 1991.
82. J. Erikson, M.Z. Radic, S.A. Camper, R.R. Hardy, C, Carmack and M. Weigert. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349, 331-4, 1991.
83. A. Strasser, S. Whittingham, D.L. Vaux, M.L. Bath, J.M. Adams, S. Cory and A.W. Harris. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease, Proc. Natl. Acad. Sci. USA 88, 8661-5, 1991.
84. M.S. Spector, S. Desnoyers, D.J. Hoeppner and M.O. Hengartner. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 385, 653-6, 1997.
85. R.M. Kluck, W.E. Bossy, D.R. Green and D.D. Newmeyer. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-6, 1997.
86. A. Strasser, A.W. Harris, D.C. Huang, P.H. Krammer and S. Cory. Bcl-2 and Fas/ APO-1 regulate distinct pathways to lymphocyte apoptosis. Embo. J. 14, 6136-47, 1995.
87. M.A. Desai, L. Lu, G.R. Ramsey and S.K. Datta. Hyperexpression of CD40 hgand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Inv. 97, 2063-73, 1996.
88. M. Koshy, D. Berger and M.K. Crow. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Inv. 98, 826-37, 1996.
89. P.L. Cohen and R.A. Eisenberg. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today 13, 427-8, 1992.
90. D. Nemazee, C. Guiet, K. Buerki and R.A. Marshak. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras. J. Immunol. 147, 2536-9, 1991.
91. S. Hirose, K. Yan, M. Abe, Y. Jiang, Y. Hamano, H. Tsurui and T. Shirai. Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. Proc. Natl. Acad. Sci. USA 94, 9291-5, 1997.
92. J.S. Bignon and K.A. Siminovitch. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. & Immunopath. 73, 168-79, 1994.
93. S. Sato, A.S. Miller, M. Inaoki, C.B. Bock, P.J. Jansen, M.L. Tang and T. F. Tedder. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signai transduction: altered signaling in CD22-deficient mice. Immunity 5, 551-62, 1996.
94. K.L. Otipoby, K.B. Andersson, K.E. Draves, S.J. Klaus, A.G. Farr, J.D. Kerner, R.M. Perlmutter, C.L. Law and E.A. Clark. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384, 634-7, 1996
95. T.L. O'Keefe, G.T. Williams. S.L. Davies and M.S. Neuberger. Hyperresponsive B cells in CD22-deficient mice. Science 274, 798-801, 1996.
96. L. Nitschke, R. Carsetti, B. Ocker, G. Kohler and M C. Lamers. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol 7, 133-43, 1997.